As cells with KIF5B/RET fusion gene overexpress the chimeric RET receptor tyrosine kinase and show spontaneous cellular transformation [20], inhibiting RET receptor tyrosine kinase may suppress tumor progression of KIF5B-RET fusion-positive lung cancer [20, 21]. The gene discussed is RET; the disease is lung cancer.